Koers Pure Global Cannabis Inc Toronto S.E.
Aandelen
RSL
CA7806782073
Farmaceutische producten
Omzet 2017 | - | Omzet 2018 | - | Marktkapitalisatie | 24,16 mln. 33,03 mln. 22,29 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | - 0 0 | Nettowinst (verlies) 2018 | -23 mln. -31,45 mln. -21,22 mln. | EV/omzet 2017 * | - |
Nettoschuld 2017 | 211K 288K 195K | Nettoschuld 2018 | 4,49 mln. 6,14 mln. 4,14 mln. | EV/omzet 2018 | - |
K/w-verhouding 2017 * |
-
| K/w-verhouding 2018 |
-0,72
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 83,64% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Vik Chopra
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjeev Goel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Lavergne
PRN | Corporate Officer/Principal | - | 30-07-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jane E. Pagel
BRD | Director/Board Member | - | 01-07-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+38,28% | 6,29 mld. | |
-16,91% | 4,42 mld. | |
+5,14% | 3,3 mld. | |
-14,63% | 3,05 mld. | |
-4,12% | 2,47 mld. | |
+42,14% | 1,94 mld. | |
-10,63% | 1,66 mld. | |
-2,71% | 1,61 mld. | |
-12,26% | 1,54 mld. |